Modern Spirometry, 24/7
Wherever you are, whatever you do.
Wellbri represents a breakthrough in respiratory diagnostics.
We combine medtech, artificial intelligence, and digital health into a single solution. Our mobile spirometer, designed as a mask with a mobile app, enables continuous monitoring of lung function, and the collected data can be integrated with EMR/EHR systems.
Through AI technology, we are pioneering a new era of personalized prevention, telemedicine, and early diagnosis of lung diseases.
A globally scalable solution, ready for B2B, B2C, and white-label development.
*Wellbri is currently in the development phase. The device does not yet have CE certification as a medical device; the certification process is underway.
The Market Awaits a Breakthrough in Respiratory Diagnostics
The need to shift respiratory testing from clinical settings to daily life and mobile applications has never been greater.
- Over 300 million people worldwide suffer from asthma or COPD.
- Spirometry is currently difficult to access, characterized by long waiting times, stationary equipment, and limited scalability.
- Telemedicine and preventive care are driving demand for D2C and B2B solutions.
Wellbri addresses these challenges by offering modern spirometry available 24/7.
Solution
Wellbri – a mobile spirometer with AI and a mobile app.
Professional respiratory diagnostics always at your fingertips.
Why Wellbri?
It combines medtech, artificial intelligence, and well-being, enabling daily monitoring of lung health – at home, at work, and during physical activity.
Precise measurements in minutes.
Thanks to the Wellbri mobile spirometer, you receive accurate data on your lung function..
AI analyzes the results.
Artificial intelligence algorithms compare measurements with norms and generate personalized recommendations..
Reports with one click.
Share results with your doctor or medical team in seconds.
Scalable sales model.
B2B and D2C – subscriptions, devices, white-label, available for both individual customers and business partners..
How Wellbri Works?
Your mobile spirometer for 24/7 lung health monitoring.
4 simple steps to control your breathing:
Step 1
Launch and connect the device with the mobile app.
Step 2
Perform the test – a calm inhale and a maximal exhale.
Step 3
AI analyzes the results in real-time and generates personalized recommendations.
Step 4
Receive the report in the app, ready to be saved or sent to a doctor.
Technology and Competitive Advantages
Wellbri combines precise medical diagnostics, artificial intelligence, and mobility in one device.
Wellbri łączy precyzyjną diagnostykę medyczną, sztuczną inteligencję i mobilność w jednym urządzeniu.
- Mobility and 24/7 measurements – a compact device for daily use.
- Triple-sensor design (market standard is a single sensor) → higher precision and reliability of respiratory measurements.
- AI algorithms analyzing results and generating recommendations.
- Integration with telemedicine and EHR/EMR systems – doctor-ready reports.
- iOS/Android mobile app with an intuitive interface.
- Medical standards – designed in accordance with CE/ISO (in progress).
- Detection of abnormalities in the respiratory tract, sleep apnea, and causes of snoring.
- Potential for well-being, sports, and preventive functions – development of personalized prevention.
Wellbri Enters the Market Scalably
Responding to the growing needs for respiratory health in homes, companies, and sports clubs.
Business Model
Monetization at multiple levels.
- Hardware + app subscription – AI, reports, and trend analysis.
- D2C – sale of devices with a monthly subscription.
- B2B – partnerships with clinics, insurance companies, employers, and sports clubs.
- White-label – licensing of technology for partners.
Market
Growing and ready for innovation.
- Global spirometer market: ~$1.5 billion USD (CAGR >9%).
- Telemedicine and mobile health: >$250 billion USD by 2030.
- Wellness and self-care trends → growing adoption of home devices.
- Target groups (sweet spots): asthma, COPD, athletes, well-being.
Go-To-Market
A well-thought-out market entry strategy.
- Start in Poland → quick product validation.
- Channels: online sales, partnerships with clinics, cooperation with insurers and sports clubs.
- Communication: health education, well-being and self-care, storytelling for users and partners.
Team
A team with experience and complementary competencies.
Sebastian Szczepański
CEO, Founder
An expert in pharmacy and medical innovation. He has over 20 years of experience in developing healthcare products, distribution and logistics of medical products, and managing sales forces. He has led R&D projects and implemented medtech solutions in Poland and abroad. Team leader, responsible for strategy, fundraising, and medical certification.
Piotr Klaja
Co-founder, Head of Business Development
Over 20 years of experience in the pharmaceutical, FMCG, and healthcare sectors. He has worked in managerial positions in international companies, managed sales in Central and Eastern European markets, and was responsible for building distribution channels and scaling businesses. At Wellbri, he is responsible for B2B strategy, partnerships, and international expansion.
Support
Technological and medical advisors.
Specialists in electronics, respiratory sensors, artificial intelligence, and medical regulations (CE/ISO). Cooperating pulmonologists and family doctors support the clinical validation process.
Invest in the Future of Spirometry!
An investment that breathes the future.
We are opening a seed round – we are looking for a strategic investor.
Structure: up to 30% equity.
Funds allocated for:
2025 – finalization of MVP and obtaining medical certification (CE/ISO).
2026 – development of the AI application, trend analysis, and integration with telemedicine systems.
2027 – expansion in the EU and commercialization of B2B and D2C.
Roadmap:
Etap 1
Building the MVP, internal tests, preparation for certification.
Etap 2
First B2B partnerships, sales in Poland, development of the application with an AI module.
Etap 3
Integrations with telemedicine systems, entry into the EU market, preparation for global expansion.
Join us and become part of the revolution in lung health monitoring.
Dołącz do nas i pomóż zbudować przyszłość spirometrii!
Inwestycja, która oddycha przyszłością.
- Otwieramy rundę seed: poszukujemy inwestora strategicznego.
- Struktura: do 30% equity.
- Środki przeznaczone na:
- dokończenie MVP i certyfikację (2025),
- rozwój aplikacji AI i integracji (2026),
- ekspansję UE i komercjalizację (2027).
Wellbri
Privacy policy
Terms of use